Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Exelixis Eyes Liver Cancer OK To Help Drive Cabometyx Sales
Mar 16 2018
•
By
Kevin Grogan
CELESTIAL data could get Exelixis another approval for Cabometyx • Source: Shutterstock
More from Anticancer
More from Therapy Areas